Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |